ERAS NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Erasca Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 19.11 USD
-0.3% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 39.7% above the Trend Line and sits at 77.5% of its 52-week range. The latest completed week returned -0.3%, after a 19.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bearish with 37/100 conviction, while the latest news-sentiment score is 40/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.

Setup score 64 out of 100
Latest Close 19.11 USD 24 Jul 2026
1W Return -0.3% latest completed week
4W Return 19.4% short-term follow-through
12W Return 90.5% quarterly tape
Trend Breadth 92.3% 48 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • The trend backdrop is active with a 48-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 1 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.3% Latest completed week; four-week move 19.4%. Indicator stack 96/60 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 65.00% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bearish 37/100 conviction; expected move 25.0%. News sentiment 40/100 70 relevant articles in the latest sentiment read. Event risk 11d Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 39.7% above the Trend Line and sits at 77.5% of its 52-week range. The latest completed week returned -0.3%, after a 19.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5512-week average 0.64

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.55Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers

No recent accumulation markers. 1 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 19.4% over four weeks, 90.5% over 12 weeks, and 998.3% over one year. The current trend has remained active for 48 consecutive weeks.

Performance by holding period

1W-0.3%
4W19.4%
12W90.5%
26W91.9%
52W998.3%
Active trend streak48 weeks
Active weeks in one year48
Trend breadth92.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.06Latest activity-pressure read.
Pressure change109.6%Four-week change in activity pressure.
Leadership102.88Latest relative-leadership reading.
RS change14.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 67% Model confidence 64%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength62/100Blend of value, momentum, and quality. Underlying universe rank 39; rank 1 is best.
Value55/100Relative valuation strength. Underlying universe rank 46; rank 1 is best.
Quality54/100Profitability and accounting quality. Underlying universe rank 47; rank 1 is best.
Momentum56/100Medium-term price momentum. Underlying universe rank 45; rank 1 is best.
Growth56/100Revenue and earnings growth. Underlying universe rank 45; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-1.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-52.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-3.9%
Net share repurchases relative to market value.
Shareholder yield
-3.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

ERAS shows bearish options pressure with a 37/100 conviction score, put-call volume ratio of 5.21, expected move of 25.0%, and Sharemaestro trend signal active.

Conviction37/100
Expected move25.0%
Put/call volume5.21
Pressure-58
Speculation8
Volatility96
Trend agreement5
Open options detail
Insider activity7 / 2

7 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment40/100

Weighted news tone is neutral across 70 relevant articles.

9 positive · 42 neutral · 19 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
Options expected move25.0%Nearest-chain priced movement where available.
52-week drawdown-21.3%Distance below the 52-week high.
13-week volatility17.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher19 of 267 weeks finished lower.
Best week+19.0%Week of 3 Apr.
Worst week-53.3%Week of 1 May.
Latest week-0.3%Week of 24 Jul.

Shape of recent returns

Strong gains14
Modest gains5
Flat weeks0
Modest losses3
Sharp losses4
Recent vol17.6%13-week weekly-return volatility.
Base vol17.2%52-week weekly-return volatility.
Up/down split37/15Count of positive and negative weeks in the 52-week window.
Average skew11.9% / -8.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape64/100

Trend, activity pressure, participation, and risk combine to a 64/100 tape read.

 Indicator analysis64/100

Latest 12-week confirmation: trend 12/12, activity pressure 2/12, relative leadership 12/12.

Activity pressure 0.55; 1 reversal markers Next-Week ExpectancyPositive 65.00%

Next-week expectancy is positive with a 65.00% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors56/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 81; Small Cap Core rank 51 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options33/100

ERAS shows bearish options pressure with a 37/100 conviction score, put-call volume ratio of 5.21, expected move of 25.0%, and Sharemaestro trend signal active.

Bearish · Put-side pressure · Expected move 25.0% Sentiment40/100

Weighted news tone is neutral across 70 relevant articles.

ERASCA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Insiders7 / 2

7 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings11d

Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202619.11 USD-0.3%13.68 USD4.39 USD0.06102.8816.2MOn
17 Jul 202619.17 USD3.5%13.16 USD4.28 USD-0.03107.4738.3MOn
10 Jul 202618.53 USD0.3%12.63 USD4.18 USD-0.2899.3823.0MOn
3 Jul 202618.47 USD15.4%12.14 USD4.08 USD-0.46109.5421.4MOn
26 Jun 202616.01 USD17.1%11.63 USD3.98 USD-0.6490.0941.9MOn
19 Jun 202613.67 USD-2.7%11.20 USD3.89 USD-0.8160.2421.0MOn
12 Jun 202614.05 USD17.4%10.84 USD3.82 USD-0.9073.6921.9MOn
5 Jun 202611.97 USD-6.8%10.46 USD3.75 USD-0.9955.8536.4MOn
29 May 202612.84 USD14.2%10.14 USD3.69 USD-1.0463.6820.0MOn
22 May 202611.24 USD9.9%9.79 USD3.63 USD-0.8751.4518.9MOn
15 May 202610.23 USD1.1%9.49 USD3.57 USD-0.1443.0518.5MOn
8 May 202610.12 USD0.9%9.23 USD3.52 USD0.5544.3424.1MOn
1 May 202610.03 USD-53.3%8.98 USD3.48 USD1.0754.35109.8MOn
24 Apr 202621.49 USD13.0%8.72 USD3.43 USD1.41243.8043.0MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.